ARCHIVES

Afinitor and Sutent Approved For Pancreatic Neuroendocrine Tumors

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Director Broder, Going On 3rd Year, Examines Issues Of Funding, Priorities, For Institute’s Future

September 20, 1991

American Health Fdn. Honors NCI On Act’s 20th Anniversary

December 13, 1991

New Organ Systems Concept Flow Discussed

October 18, 1985

2015 Breakthrough Prize Winners Announced at Gala

November 14, 2014

Letter to the Editors: BSA P01 Review Vote Was Advisory, NCI Official Says

December 5, 1997

NCI-Approved Clinical Trials

May 28, 2004